Please use this identifier to cite or link to this item:
|Title:||Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease||Authors:||Tan, E.K.
|Issue Date:||Mar-2009||Citation:||Tan, E.K., Lee, J., Chen, C.P., Wong, M.C., Zhao, Y. (2009-03). Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease. Neurobiology of Aging 30 (3) : 501-502. ScholarBank@NUS Repository. https://doi.org/10.1016/j.neurobiolaging.2007.07.010||Abstract:||Alzheimer's disease (AD) pathology has been described in Parkinson's disease (PD) patients with leucine-rich repeat kinase-2 (LRRK2) mutations. A common LRRK2 Gly2385Arg variant has been widely shown to be associated with a twofold increased risk of PD in various Asian populations. In a case control study, the frequency of the heterozygous Gly2385Arg genotype was demonstrated in 4.3% of AD compared to 4.5% in controls (odds ratio = 0.94, 95% CI 0.37-2.42, p = 1.0). The Gly2385Arg variant does not appear to modulate the risk of AD in our population. © 2007 Elsevier Inc. All rights reserved.||Source Title:||Neurobiology of Aging||URI:||http://scholarbank.nus.edu.sg/handle/10635/129480||ISSN:||01974580||DOI:||10.1016/j.neurobiolaging.2007.07.010|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.